Dino Mehic
@dinomehic.bsky.social
MD PhD | Physician Scientist at Medical University of Vienna | Thrombosis and Haemostasis | Hematology
Reposted by Dino Mehic
🌟 #ECTH2025 is just around the corner! 🌟
Join us in Prague to explore the latest discoveries in #thrombosisandhaemostasis in a beautiful place rich in culture.
🔗 Register here to secure early bird rates: www.ecth.org/registration/
Curious about CzechFunFact #2?
#ECTH2025 #ECTHJAB #CzechFunFacts
Join us in Prague to explore the latest discoveries in #thrombosisandhaemostasis in a beautiful place rich in culture.
🔗 Register here to secure early bird rates: www.ecth.org/registration/
Curious about CzechFunFact #2?
#ECTH2025 #ECTHJAB #CzechFunFacts
June 11, 2025 at 10:25 PM
🌟 #ECTH2025 is just around the corner! 🌟
Join us in Prague to explore the latest discoveries in #thrombosisandhaemostasis in a beautiful place rich in culture.
🔗 Register here to secure early bird rates: www.ecth.org/registration/
Curious about CzechFunFact #2?
#ECTH2025 #ECTHJAB #CzechFunFacts
Join us in Prague to explore the latest discoveries in #thrombosisandhaemostasis in a beautiful place rich in culture.
🔗 Register here to secure early bird rates: www.ecth.org/registration/
Curious about CzechFunFact #2?
#ECTH2025 #ECTHJAB #CzechFunFacts
Reposted by Dino Mehic
So inspiring to see the #ISTHearlycareer leaders play important roles to advance many @isth.org program. Learn more about ISTH #SSC Co-Chairs and their important contributions:
➡️Gael Marrow
➡️@dinomehic.bsky.social
➡️@aaron-iding.bsky.social
➡️Cheryl Maier
Read more here: bit.ly/3XOmNCI
➡️Gael Marrow
➡️@dinomehic.bsky.social
➡️@aaron-iding.bsky.social
➡️Cheryl Maier
Read more here: bit.ly/3XOmNCI
April 9, 2025 at 2:29 PM
So inspiring to see the #ISTHearlycareer leaders play important roles to advance many @isth.org program. Learn more about ISTH #SSC Co-Chairs and their important contributions:
➡️Gael Marrow
➡️@dinomehic.bsky.social
➡️@aaron-iding.bsky.social
➡️Cheryl Maier
Read more here: bit.ly/3XOmNCI
➡️Gael Marrow
➡️@dinomehic.bsky.social
➡️@aaron-iding.bsky.social
➡️Cheryl Maier
Read more here: bit.ly/3XOmNCI
Very interesting data on the role of fibrin film in health and disease by @fibrin-fraser.bsky.social @ GTH2025 in Lausanne
February 21, 2025 at 10:35 AM
Very interesting data on the role of fibrin film in health and disease by @fibrin-fraser.bsky.social @ GTH2025 in Lausanne
Interesting case-report from Germany on a successful treatment of multi-refractory primary immune thrombocytopenia using CD19 CAR T-cell therapy. Could this be a therapeutic option for multi-refractory ITP? www.thelancet.com/journals/lan...
January 3, 2025 at 11:01 PM
Interesting case-report from Germany on a successful treatment of multi-refractory primary immune thrombocytopenia using CD19 CAR T-cell therapy. Could this be a therapeutic option for multi-refractory ITP? www.thelancet.com/journals/lan...
🎄🎄🎄
End-of-the-year get-together at the Christmas dinner/party of our Thrombosis and Haemostasis Research Group in Vienna.
Happy, proud & grateful what the team has achieved this year with many contributions to science & education.
Thank you to each team member - looking forward to continue our work!
Happy, proud & grateful what the team has achieved this year with many contributions to science & education.
Thank you to each team member - looking forward to continue our work!
December 26, 2024 at 8:02 PM
🎄🎄🎄
Reposted by Dino Mehic
Did anyone else get excited to see this Late Breaking Clinical Trial appear for #ASH24? Really important data on low- vs. standard-dosing DOACs for long-term treatment of VTE. However, results are complex... will they change practice?
ash.confex.com/ash/2024/web...
ash.confex.com/ash/2024/web...
Paper: Extended Treatment of Venous Thromboembolism with Reduced- Vs Full-Dose Direct Oral Anticoagulants in Patients at High Risk of Recurrence
ash.confex.com
November 25, 2024 at 8:07 PM
Did anyone else get excited to see this Late Breaking Clinical Trial appear for #ASH24? Really important data on low- vs. standard-dosing DOACs for long-term treatment of VTE. However, results are complex... will they change practice?
ash.confex.com/ash/2024/web...
ash.confex.com/ash/2024/web...